Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06083766 · ClinicalTrials.gov registry record
Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People
A clinical trial of Effects of GAHT, on Skeletal Muscle in TGD, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT06083766 is a study of Effects of GAHT, on Skeletal Muscle in TGD that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06083766, a study of Effects of GAHT, on Skeletal Muscle in TGD, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.
Conditions Studied
Interventions
- BEHAVIORAL hormone therapy
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06083766
The ClinicalTrials.gov registry entry for NCT06083766 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Effects of GAHT, on Skeletal Muscle in TGD appearing as the primary indexed condition, and to 1 intervention - of which hormone therapy is the first listed.
NCT06083766 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06083766 about?
NCT06083766 is a clinical study titled "Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People". The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.
What is the current status of trial NCT06083766?
This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2024-01-04. Estimated completion is 2026-07.
What conditions does trial NCT06083766 study?
This clinical trial studies the following conditions: Effects of GAHT, on Skeletal Muscle in TGD.
What interventions are being tested in trial NCT06083766?
The interventions under investigation include: hormone therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06083766?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06083766 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.